De Burlo Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-180
Closed -$17.2K 104
2022
Q3
$17.2K Buy
+180
New +$17.8K ﹤0.01% 135
2022
Q2
Sell
-180
Closed -$18.2K 116
2022
Q1
$18.2K Buy
+180
New +$18.9K ﹤0.01% 133
2017
Q2
Sell
-19,605
Closed -$1.54M 104
2017
Q1
$1.54M Sell
19,605
-1,150
-6% -$91.8K 0.33% 58
2016
Q4
$1.64M Sell
20,755
-1,700
-8% -$138K 0.4% 60
2016
Q3
$2M Sell
22,455
-34,951
-61% -$3.3M 0.55% 64
2016
Q2
$5.5M Sell
57,406
-39,150
-41% -$3.9M 1.33% 32
2016
Q1
$10M Sell
96,556
-400
-0.4% -$38.9K 2.9% 8
2015
Q4
$9.48M Sell
96,956
-17,400
-15% -$1.7M 2.23% 13
2015
Q3
$11M Buy
114,356
+33,100
+41% +$3.48M 2.59% 7
2015
Q2
$8.52M Buy
81,256
+8,300
+11% +$848K 1.78% 19
2015
Q1
$7.53M Buy
72,956
+27,950
+62% +$2.83M 1.49% 23
2014
Q4
$4.33M Buy
45,006
+41,200
+1,083% +$3.63M 0.88% 50
2014
Q3
$303K Buy
+3,806
New +$300K 0.07% 92
2014
Q2
Sell
-3,806
Closed -$285K 103
2014
Q1
$285K Hold
3,806
0.07% 84
2013
Q4
$272K Hold
3,806
0.06% 90
2013
Q3
$216K Hold
3,806
0.06% 92
2013
Q2
$218K Buy
+3,806
New +$221K 0.06% 87

Other funds holding CVS

De Burlo Group's CVS Position: Q4 2022 in Review

De Burlo Group sold out of CVS Health (CVS) in Q4 2022, closing a stake of 180 shares — an estimated $17.2K sold.

De Burlo Group first reported a position in CVS in Q2 2013 and held it in 17 quarters. The position peaked at $11M in Q3 2015. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • De Burlo Group reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • De Burlo Group sold 180 CVS Health shares in Q4 2022, an estimated $17.2K.
  • De Burlo Group first reported a position in CVS Health in Q2 2013 and held it in 17 quarters.
  • De Burlo Group's CVS Health position peaked at $11M in Q3 2015.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on De Burlo Group's 13F filing for Q4 2022, filed 14 Feb 2023.